[Insulin lipoatrophy and its elimination through the use of monocomponent insulin]
- PMID: 1035452
[Insulin lipoatrophy and its elimination through the use of monocomponent insulin]
Abstract
Since their first description 50 years ago severe forms of lipoatrophy appearing above all in girls and women are occasionally a cosmetically significant and therapeutically problematic side effect of the insulin treatment of diabetes mellitus. On two own female patients is shown, how the hitherto recommended measures failed in distinctive cases and only the treatment with monocomponent-insulin of the pig led to the restoration of the fatty tissue. The successful therapy of lipoatrophy with monocomponent insulin in all cases hitherto published confirms the hypothesis that a local antigen-antibody-reaction to highly molecular constituents of the commercial mixed insulins causes the atrophy of fatty tissue.
Similar articles
-
[The place of "monocomponent" insulins in diabetes mellitus therapy].Schweiz Med Wochenschr. 1975 Apr 19;105(16):485-94. Schweiz Med Wochenschr. 1975. PMID: 1215860 German.
-
[Insulin-induced lipoatrophy--caused by monocomponent insulin?].Orv Hetil. 1989 Dec 17;130(51):2751-2. Orv Hetil. 1989. PMID: 2689957 Hungarian.
-
Treatment of insulin lipoatrophy with monocomponent insulin.Diabetologia. 1974 Jun;10(3):211-4. doi: 10.1007/BF00423037. Diabetologia. 1974. PMID: 4845721 No abstract available.
-
[Significance of the preparative insulin chemistry for clinical diabetology].Dtsch Med Wochenschr. 1973 Nov 23;98(47):2256-8. Dtsch Med Wochenschr. 1973. PMID: 4271376 Review. German. No abstract available.
-
[Advantages and drawbacks of human insulin].Schweiz Med Wochenschr. 1991 Apr 6;121(14):475-81. Schweiz Med Wochenschr. 1991. PMID: 2035004 Review. German.
Cited by
-
Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.Eur J Pediatr. 1978 Jun 20;128(2):89-102. doi: 10.1007/BF00496994. Eur J Pediatr. 1978. PMID: 566669